Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 4 min ago
Peer-reviewedCC BY 4.0Communications Medicine

Governing accelerated evidence in real-time clinical trials

Abstract

The FDA’s real-time clinical trial initiative marks a pivotal shift in regulating clinical trials, yet accelerating data flows may outpace the governance, statistical safeguards, and inclusive infrastructure required for trustworthy evidence. To address these issues, the commentary identifies four key challenges and proposes a three-pillar governance framework to ensure rigorous, equitable, and continuously adaptive oversight and operations.

Related

  1. Dermatologic Toxicities Associated with Tebentafusp for Uveal Melanoma: A Review of Clinical Trials and Real-World Evidence.
    Ioannis-Alexios Koumprentziotis, Aikaterini Bakella, Vasiliki Nikolaou +1
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  2. Clinical Evidence of Orally Administered Herbal Preparations for Supportive Cancer Care: A PRISMA Systematic Review of Randomized Clinical Trials (1990–2026)
    Rebeca Moreno-Ponce, Uriel Díaz-Llerenas, Gustavo A. Hernández-Fuentes +12
    Medical sciences (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Azacitidine-Venetoclax in Elderly and Unfit Acute Myeloid Leukemia: Real-World Outcomes Outside Clinical Trials.
    Manlio Fazio, Demetrio Gabriele Gerace, Giuseppe Mirabile +9
    Hematology reportsPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Mechanism-based therapeutic strategies in cardiovascular-kidney-metabolic syndrome: integrating biological pathways with evidence from clinical trials
    John Nzobokela, Simweene C. Choolwe, Sepiso K. Masenga
    Frontiers in EndocrinologyPeer-reviewedCC BY 4.0Full textEndocrinology & metabolismCrossrefPMC
  5. Accelerated Approvals and Clinical Evidence for Medications for Children
    Nuzhat Mahbub, Sujata Purja, Chul S. Hyun +4
    JAMA Network OpenPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossrefPMC
BibTeX
@article{seixas2026governing,
  title = {{Governing accelerated evidence in real-time clinical trials}},
  author = {Azizi A. Seixas},
  journal = {Communications Medicine},
  year = {2026},
  month = oct,
  doi = {10.1038/s43856-026-01909-8},
  url = {https://www.nature.com/articles/s43856-026-01909-8},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Governing accelerated evidence in real-time clinical trials
AU  - Azizi A. Seixas
PY  - 2026
DA  - 2026/10/28
JO  - Communications Medicine
DO  - 10.1038/s43856-026-01909-8
UR  - https://www.nature.com/articles/s43856-026-01909-8
AB  - The FDA’s real-time clinical trial initiative marks a pivotal shift in regulating clinical trials, yet accelerating data flows may outpace the governance, statistical safeguards, and inclusive infrastructure required for trustworthy evidence. To address these issues, the commentary identifies four key challenges and proposes a three-pillar governance framework to ensure rigorous, equitable, and continuously adaptive oversight and operations.
SN  - 2730-664X
ER  -